BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu K, He Z, Chen M, Wang N, Zhang D, Yang L, Xu Z, Xu H. HIF-1α regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors. Cell Death Dis 2020;11:586. [PMID: 32719331 DOI: 10.1038/s41419-020-02768-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu K, Zhang Q, Chen M, Li B, Wang N, Li C, Gao Z, Zhang D, Yang L, Xu Z, Li X, Xu H. N6-methyladenosine modification regulates imatinib resistance of gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1. Cancer Lett 2022:S0304-3835(22)00016-7. [PMID: 35032557 DOI: 10.1016/j.canlet.2022.01.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shima T, Taniguchi K, Tokumaru Y, Inomata Y, Arima J, Lee SW, Takabe K, Yoshida K, Uchiyama K. Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells. Oncol Rep 2022;47:7. [PMID: 34738628 DOI: 10.3892/or.2021.8218] [Reference Citation Analysis]
3 Zeng W, Xing Z, Tan M, Wu Y, Zhang C. Propofol regulates activated macrophages metabolism through inhibition of ROS-mediated GLUT1 expression. Inflamm Res 2021;70:473-81. [PMID: 33751130 DOI: 10.1007/s00011-021-01449-y] [Reference Citation Analysis]
4 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Reference Citation Analysis]